Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Masson Kristina, holds the title of EVP - Business Operations at Acrivon Therapeutics, Inc..
On 2026-11-17, the insider transacted 1,780 shares.The shares were transacted at a weighted average price of $1.45 per share, resulting in a total market-relevant value of $3K.
Masson Kristina (EVP - Business Operations) sold $3K of $ACRV
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.